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dialogues between manufacturers and HTA bodies to generate robust utility data. 
Economic evaluation of pharmaceuticals in France will follow a learning curve for 
both the manufacturers and for HAS.
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Objectives: Since 2010, there has been established a Polish EQ-5D value set using 
the time trade-off (TTO) method. Pharmacy students gain a professional knowledge 
on health problems and treatment during their education. The aim of this study 
was to assess how do medical students value health on the EQ-5D compared with 
the general population and with the use of different methods of direct measure-
ment of preferences. MethOds: 135 students of the 5th year of pharmacy of the 
Wroclaw Medical University took part in the face to face interview. Students were 
asked to assess randomly selected 5 out 243 hypothetical EQ-5D-3L health states. 
Visual analogue scale (VAS), TTO and standard gamble (SG) were used. Responses 
indicating the misunderstanding of the task have been removed. Results: We 
obtained 664 useable valuations. No health state has been valued as worse than 
death. Appropriate additive models have been built: for VAS (with all coefficients 
statistically significant, R2 equal to 0.488, and the worst possible health state valued 
as 0.089), for TTO (with all coefficients statistically significant except for constant 
and UA2, R2 equal to 0.292, and the worst possible health state valued as 0.540) and 
for SG (with all coefficients statistically significant except for constant and AD2, R2 
equal to 0.196, and the worst possible health state valued as 0.582). With the use 
of TTO, almost all health states were valuated higher by the pharmacy students 
compared to data of the general population cOnclusiOns: Pharmacy students 
have a tendency to value health states higher than the general population. The 
valuation highly depends on the method used.
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Objectives: To develop a set of weights for EQ-5D-3L health states based on the val-
ues of a representative sample of the Hungarian population. MethOds: A national 
population survey (n= 5,503) containing self-reported health status were analysed to 
identify respondent’s EQ-5D-3L health state. The survey also included a visual ana-
logue scale (VAS) rating of the respondent’s health on a 0-100 scale. Mean VAS rating 
for each observed EQ-5D-3L state were computed, yielding an average value for each 
“naturally” occurring EQ-5D health states. OLS regression yielded a well-behaved set 
of coefficients representing the value loss for each problem level/dimension. This 
estimation model was then applied to create a value set for all 243 EQ-5D-3L health 
states. Results: The most frequently reported health state was 11111 (48.6%) with 
a mean VAS rating of 82.5. The worst health state was rated at 25.4, represent-
ing a somewhat compressed range of values. Logically consistent coefficients for 
all 5 dimensions revealed largest value losses for Pain/Discomfort and Anxiety/
Depression level#3. Self-care level#2 produced the smallest value loss. Values for all 
243 health states were estimated using the derived value loss function. The value 
for dead generated in the European BIOMED was used to transform these estimated 
values onto a 0-1 format suitable for use in QALY calculations. cOnclusiOns: In 
common with other countries, many Hungarian analysts use the UK MVH value 
set as a stop-gap. This expedient provides a means of satisfying the requirements 
for QALY calculations but risks compromising the principle that social decision-
maker should use values of the relevant population. Substitution of UK values may 
be empirically unsound. An alternative value set for EQ-5D-3L based on data from 
national Hungarian sources is now available, providing a robust counter-factual 
for comparative analysis.
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Objectives: To evaluate health state utility values in mild and severe primary 
dysmenorrhea (PD) in patients and controls. MethOds: A convenience sample 
of female university students and staff was invited to participate in a web-based 
survey. Inclusion criteria to the study were: i) aged 18 to 40 years; ii) nulliparous 
and not pregnant at the time of the survey; iii) having menstrual periods; and iv) no 
pelvic pathology. Subjects reporting a history of menstrual cramps with an onset of 
> 20 years of age were excluded. Participants with pain intensity of > 3 on an 11-point 
numeric rating scale were classified as patients, whereas those without history of 
menstrual cramps or with pain intensity of ≤ 3 were considered as controls. The 
10-year time trade-off was applied to assess utilities for two hypothetical PD health 
states characterised by menstrual cramps and associated symptoms. Results: 
Altogether 556 adults were completed the questionnaire with mean age of 23±3.5 
years. Of these, 399 (72%) reported symptoms of PD and 157 (28%) were grouped as 
controls. Overall 19%, 49% and 32% had mild, moderate or severe PD based on the 
verbal multidimensional scoring system for assessment of dysmenorrhea severity. 
Mean utilities for the mild and severe hypothetical health states were 0.97±0.14 and 
0.88±0.24, p< 0.001. Compared to the control group, PD patients attached significantly 
lower utilities to the mild health state (0.96 vs. 0.99, p= 0.011) but not to the severe 
(0.86 vs. 0.90, p= 0.420). cOnclusiOns: This study provides the first utility values 
in PD. Disutility experienced in PD – ranging between 0.01 and 0.14 depending on 
severity and the group who valued them – is definitely not negligible. Severe PD 
may have a similar impact on utilities as living with chronic migraine. Utilities 
evaluated in this study can be used as inputs for cost-effectiveness analyses of 
health interventions.
Objectives: Time tradeoff (TTO) values of the EQ-5D-5L health states measured 
in China’s EQ-VT study varied across sampled locations. This might be a sign of 
different health preferences in those locations, or it might be a sign of salient inter-
viewer effects or respondent’s differing understanding of the TTO task. Task under-
standing could be assessed in terms of individual-level inconsistency in valuation. 
Relating inconsistency to the characteristics of the respondent, interviewer, and 
interview can therefore help to understand the variations in values. MethOds: 20 
Interviewers interviewed 1,296 respondents and each respondent valued 10 health 
states using the EQ-VT (TTO) protocol in 5 cities in China. At the respondent level, 
inconsistency in valuation was assessed in terms of severity and quantity and was 
then related to respondent’s background characteristics, interviewer identity, and 
performance of TTO tasks and the data that related to the ‘wheelchair example’ 
which is used to train the respondent. An Ordered logistic regression were used for 
statistical analysis. Results: In the full dataset, no relation between respondent’s 
education and inconsistency was found, nor did a relation between location and 
inconsistency exist. However, we did find a positive association between time spent 
on TTO tasks and inconsistency and a negative association between time spent on 
the wheelchair example and inconsistency. In addition, respondents interviewed 
by one particular interviewer were found to be highly inconsistent. After excluding 
the data collected by this interviewer, the remaining 19 interviewers were similar in 
the inconsistency level, and the relation between interview process and inconsist-
ency was stronger. cOnclusiOns: Inconsistency strongly related to interviewer 
and then to interview process, but has limited association with respondents’ back-
ground variables. This result, in turn, suggests that the variance in values between 
locations is not due to differences in understanding the task, but possibly due to 
different health preferences.
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Objectives: The purpose of this study was to measure the population norms for 
the Japanese versions of preference-based measures (EQ-5D-3L, EQ-5D-5L and 
SF-6D). We also considered the relations between QOL score in the general popu-
lation and socio-demographic factors. MethOds: Data in this study came from 
Ministry of Health, Labour and Welfare (MHLW) survey, which took a representa-
tive sample. A total of 1,143 adult respondents (aged ≥ 20 years) were randomly 
sampled from across Japan using data from the Basic Resident Register. The health 
status of each respondent was measured using the EQ-5D-3L, EQ-5D-5L, and SF-6D, 
and responses regarding socio-demographic data as well as subjective diseases 
and symptoms were obtained. The responses were converted to a QOL score using 
Japanese value sets. Results: The percentages of respondents with full health 
scores were 68% (EQ-5D-3L), 55% (EQ-5D-5L), and 4% (SF-6D). The QOL score meas-
ured using the SF-6D was significantly lower than those measured using either 
EQ-5D score. The QOL score was significantly lower among respondents over the 
age of 60 years, those who had a lower income, and those who had a shorter period 
of education. Intraclass correlation coefficient (ICC) showed a poor agreement 
between the EQ-5D and SF-6D scores. The differences in QOL scores between 
respondents with and those without any disease were 0.064 for the EQ-5D-3L, 
0.061 for the EQ-5D-5L, and 0.073 for the SF-6D; these differences are regarded as 
minimal important differences (MID) in the general population. cOnclusiOns: 
The Japanese population norms of three preference-based QOL measures were 
examined for the first time. Such information is useful for economic evaluations 
and research examining QOL score.
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Objectives: Economic evaluation of pharmaceuticals and medical devices has 
been introduced in France in October 2013. Economic evaluations by HAS are 
based on critical appraisals of manufacturers’ submissions. We reviewed the selec-
tion and use of health utility values for cost-utility analyses (CUA) submitted to 
HAS. MethOds: A review of manufacturers’ CUA submitted to and assessed by 
HAS by end of May 2015 was undertaken to review the identification and selection 
of data and the methods used for deriving utility estimates. The methods used 
were compared with those recommended in the HAS methodological guideline on 
economic evaluation. Results: Of the 27 submissions, 16 (56%) included utility 
values from previously published studies, only 4 of which reported a systematic 
literature review; 10 (37%) from the clinical trials informing the clinical effec-
tiveness; 2 (7%) from a mixture of sources. To describe health states, 21 (78%) 
submissions used a preference-based generic instrument, mostly the EQ-5D; 5 
(19%) used vignettes; 3 used a condition-specific instrument. Several submis-
sions used different types of instrument. In most (85%) submissions, the valua-
tion method was the time-trade off. The valuation perspective was the general 
population in 23 (85%) submissions; in only 5 (19%) submissions, the valuation 
set was derived from the French general population. In 14 (52%) submissions, 
further adjustments to utility values were made, mostly to account for adverse 
events. cOnclusiOns: We identified numerous concerns in the selection, valu-
ation and use of utility values, and a frequent lack of clarity in the description of 
the methods used. Many submissions included utility values that did not meet the 
HAS reference case for economic evaluation. There is a need to strengthen early 
